Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas W Ball

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Current Opinion in Oncology|November 30, 2006
Medullary thyroid cancer: therapeutic targets and molecular markersDouglas W Ball
Thyroid : Official Journal of the American Thyroid Association|June 9, 2009
American Thyroid Association guidelines for management of medullary thyroid cancer: an adult endocrinology perspectiveDouglas W Ball
Endocrinology and Metabolism Clinics of North America|August 4, 2007
Medullary thyroid cancer: monitoring and therapyDouglas W Ball
The Journal of Clinical Endocrinology and Metabolism|January 9, 2010
Selectively targeting mutant BRAF in thyroid cancerDouglas W Ball
Cancer Letters|March 12, 2004
Achaete-scute homolog-1 and Notch in lung neuroendocrine development and cancerDouglas W Ball
The Journal of Clinical Endocrinology and Metabolism|February 25, 2011
Clinical review: Incidentally discovered medullary thyroid cancer: diagnostic strategies and treatmentShabina R Ahmed, Douglas W Ball
Cancer Treatment and Research|March 5, 2003
Notch in malignancyDouglas W Ball, Steven D Leach
Seminars in Cancer Biology|August 4, 2004
Notch in lung development and lung cancerBrendan J Collins, Wolfram Kleeberger, Douglas W Ball
Lung Cancer (Amsterdam, Netherlands)|June 21, 2011
Insights into the achaete-scute homolog-1 gene (hASH1) in normal and neoplastic human lungMakoto Miki, Douglas W Ball, R Ilona Linnoila
Frontiers in Oncology|March 12, 2024
RET gene fusion and emergent Selpercatinib resistance in a calcitonin-rich neuroendocrine carcinoma: a case reportReza Pishdad, Peter B Illei, Christopher D Gocke, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Current Opinion in Oncology|November 30, 2006
Medullary thyroid cancer: therapeutic targets and molecular markersDouglas W Ball
Thyroid : Official Journal of the American Thyroid Association|June 9, 2009
American Thyroid Association guidelines for management of medullary thyroid cancer: an adult endocrinology perspectiveDouglas W Ball
Endocrinology and Metabolism Clinics of North America|August 4, 2007
Medullary thyroid cancer: monitoring and therapyDouglas W Ball
The Journal of Clinical Endocrinology and Metabolism|January 9, 2010
Selectively targeting mutant BRAF in thyroid cancerDouglas W Ball
Cancer Letters|March 12, 2004
Achaete-scute homolog-1 and Notch in lung neuroendocrine development and cancerDouglas W Ball
The Journal of Clinical Endocrinology and Metabolism|February 25, 2011
Clinical review: Incidentally discovered medullary thyroid cancer: diagnostic strategies and treatmentShabina R Ahmed, Douglas W Ball
Cancer Treatment and Research|March 5, 2003
Notch in malignancyDouglas W Ball, Steven D Leach
Seminars in Cancer Biology|August 4, 2004
Notch in lung development and lung cancerBrendan J Collins, Wolfram Kleeberger, Douglas W Ball
Lung Cancer (Amsterdam, Netherlands)|June 21, 2011
Insights into the achaete-scute homolog-1 gene (hASH1) in normal and neoplastic human lungMakoto Miki, Douglas W Ball, R Ilona Linnoila
Frontiers in Oncology|March 12, 2024
RET gene fusion and emergent Selpercatinib resistance in a calcitonin-rich neuroendocrine carcinoma: a case reportReza Pishdad, Peter B Illei, Christopher D Gocke, et al.
Pageof 5